ANI Pharmaceuticals, Inc.
ANIP
Jodie situation report
ANI Pharmaceuticals, Inc.'s move is being confirmed by its market group.
No new filing conclusion is available. 9 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 15 directly disclosed connections are confirming.
- At least 12 of 18 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as AVNS begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.
Who this business touches
The relationships behind ANIP
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CAHCardinal Health, Inc.partnerFeb 27, 2026 ▾
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
CORCencora, Inc.partnerFeb 27, 2026 ▾
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.”
KRKroger Company (The)partnerFeb 27, 2026 ▾
“We conduct business with all the major retail chains in the U.S.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 19 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ANIP is currently a Participant in the organic co-movement group Medical Devices & Supplies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.